Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

PLA2G4A Antikörper (N-Term)

Der Kaninchen Polyklonal Anti-PLA2G4A Antikörper wurde für WB, ELISA und IHC (p) validiert. Er ist geeignet, PLA2G4A in Proben von Human, Maus und Ratte zu detektieren.
Produktnummer ABIN7217896
-15% Promotion 2026
530,08 €
623,62 €
Sparen Sie 93,54 € (-15 %)
Zzgl. Versandkosten 20,00 € und MwSt
Lieferung nach: Deutschland
Lieferung in 10 bis 14 Werktagen

Kurzübersicht für PLA2G4A Antikörper (N-Term) (ABIN7217896)

Target

Alle PLA2G4A Antikörper anzeigen
PLA2G4A (Phospholipase A2, Group IVA (Cytosolic, Calcium-Dependent) (PLA2G4A))

Reaktivität

  • 71
  • 46
  • 15
  • 3
  • 1
  • 1
  • 1
  • 1
Human, Maus, Ratte

Wirt

  • 78
  • 8
  • 2
  • 1
Kaninchen

Klonalität

  • 73
  • 16
Polyklonal

Konjugat

  • 47
  • 8
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser PLA2G4A Antikörper ist unkonjugiert

Applikation

  • 74
  • 44
  • 24
  • 23
  • 19
  • 14
  • 14
  • 12
  • 11
  • 4
  • 2
  • 2
  • 2
  • 1
Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
  • Bindungsspezifität

    • 29
    • 7
    • 5
    • 5
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    N-Term

    Verwendungszweck

    cPLA2 Polyclonal Antibody

    Spezifität

    CPLA2 Polyclonal Antibody detects endogenous levels of cPLA2 protein.

    Aufreinigung

    The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen

    Immunogen

    Synthesized peptide derived from the N-terminal region of human cPLA2

    Isotyp

    IgG
  • Applikationshinweise

    Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB (1:500-1:2000), IHC-P (1:100-1:300), ELISA (1:20000). Not yet tested in other applications.

    Kommentare

    Primary Antibody

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    1 mg/mL

    Buffer

    PBS containing 50 % Glycerol, 0.5 % BSA and 0.02 % Sodium Azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
  • Target

    PLA2G4A (Phospholipase A2, Group IVA (Cytosolic, Calcium-Dependent) (PLA2G4A))

    Andere Bezeichnung

    cPLA2

    Hintergrund

    Rabbit Anti-cPLA2 Polyclonal Antibody,PLA2G4A, CPLA2, PLA2G4, Cytosolic phospholipase A2, cPLA2, Phospholipase A2 group IVA,PLA2G4A encodes a member of the cytosolic phospholipase A2 group IV family. The enzyme catalyzes the hydrolysis of membrane phospholipids to release arachidonic acid which is subsequently metabolized into eicosanoids. Eicosanoids, including prostaglandins and leukotrienes, are lipid-based cellular hormones that regulate hemodynamics, inflammatory responses, and other intracellular pathways. The hydrolysis reaction also produces lysophospholipids that are converted into platelet-activating factor. The enzyme is activated by increased intracellular Ca(2+) levels and phosphorylation, resulting in its translocation from the cytosol and nucleus to perinuclear membrane vesicles. Alternative splicing results in multiple transcript variants.,Cytosolic phospholipase A2

    Molekulargewicht

    observerd band 114kDa

    Gen-ID

    5321

    UniProt

    P47712

    Pathways

    Inositol Metabolic Process, G-protein mediated Events, VEGF Signaling
Sie sind hier:
Chat with us!